Evidence map›Paper›PMID 31052521›Full record

ArticleMetabolites2019

Using Pathway Covering to Explore Connections among Metabolites.

Peter E Midford, Mario Latendresse, Paul E O'Maille, Peter D Karp

Abstract read
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peter E MidfordBioinformatics Research Group, SRI, International, Menlo Park, CA 94025, USA. midford@ai.sri.com.
Mario LatendresseBioinformatics Research Group, SRI, International, Menlo Park, CA 94025, USA. latendre@AI.SRI.COM.
Paul E O'MailleBiocomplexity Sciences, SRI International, Menlo Park, CA 94025, USA. paul.omaille@sri.com.
Peter D KarpBioinformatics Research Group, SRI, International, Menlo Park, CA 94025, USA. pkarp@ai.sri.com.ORCID 0000-0002-5876-6418

Funding

Pathway-based Metabolomics Data AnalysisR03CA211814 · NCI · SRI INTERNATIONAL · PI KARP, PETER D · 2016 to 2018
$317k
National Cancer Institute R03-CA211814NCI NIH HHS R03 CA211814
6 · The paper itself

Abstract

Interpreting changes in metabolite abundance in response to experimental treatments or disease states remains a major challenge in metabolomics. Pathway Covering is a new algorithm that takes a list of metabolites (compounds) and determines a minimum-cost set of metabolic pathways in an organism that includes (covers) all the metabolites in the list. We used five functions for assigning costs to pathways, including assigning a constant for all pathways, which yields a solution with the smallest pathway count; two methods that penalize large pathways; one that prefers pathways based on the pathway's assigned function, and one that loosely corresponds to metabolic flux. The pathway covering set computed by the algorithm can be displayed as a multi-pathway diagram ("pathway collage") that highlights the covered metabolites. We investigated the pathway covering algorithm by using several datasets from the Metabolomics Workbench. The algorithm is best applied to a list of metabolites with significant statistics and fold-changes with a specified direction of change for each metabolite. The pathway covering algorithm is now available within the Pathway Tools software and BioCyc website.

Indexed as

BioCycmetabolite setsoptimizationpathwaysset theory

Identifiers

PMID31052521
PMCPMC6571860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.